Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 192

1.

COPD assessment tests scores are associated with exacerbated chronic obstructive pulmonary disease in Japanese patients.

Suetomo M, Kawayama T, Kinoshita T, Takenaka S, Matsuoka M, Matsunaga K, Hoshino T.

Respir Investig. 2014 Sep;52(5):288-95. doi: 10.1016/j.resinv.2014.04.004. Epub 2014 Jun 16.

PMID:
25169844
3.

Detection of acute deterioration in health status visit among COPD patients by monitoring COPD assessment test score.

Pothirat C, Chaiwong W, Limsukon A, Deesomchok A, Liwsrisakun C, Bumroongkit C, Theerakittikul T, Phetsuk N.

Int J Chron Obstruct Pulmon Dis. 2015 Feb 3;10:277-82. doi: 10.2147/COPD.S76128. eCollection 2015.

4.

The COPD assessment test (CAT) assists prediction of COPD exacerbations in high-risk patients.

Lee SD, Huang MS, Kang J, Lin CH, Park MJ, Oh YM, Kwon N, Jones PW, Sajkov D; Investigators of the Predictive Ability of CAT in Acute Exacerbations of COPD (PACE) Study.

Respir Med. 2014 Apr;108(4):600-8. doi: 10.1016/j.rmed.2013.12.014. Epub 2014 Jan 6.

5.

Real-world characterization and differentiation of the Global Initiative for Chronic Obstructive Lung Disease strategy classification.

Price DB, Baker CL, Zou KH, Higgins VS, Bailey JT, Pike JS.

Int J Chron Obstruct Pulmon Dis. 2014 May 28;9:551-61. doi: 10.2147/COPD.S62104. eCollection 2014.

6.

Usefulness of the Chronic Obstructive Pulmonary Disease Assessment Test to evaluate severity of COPD exacerbations.

Mackay AJ, Donaldson GC, Patel AR, Jones PW, Hurst JR, Wedzicha JA.

Am J Respir Crit Care Med. 2012 Jun 1;185(11):1218-24. doi: 10.1164/rccm.201110-1843OC. Epub 2012 Jan 26.

PMID:
22281834
7.

Mini Nutritional Assessment Short-Form predicts exacerbation frequency in patients with chronic obstructive pulmonary disease.

Yoshikawa M, Fujita Y, Yamamoto Y, Yamauchi M, Tomoda K, Koyama N, Kimura H.

Respirology. 2014 Nov;19(8):1198-203. doi: 10.1111/resp.12380. Epub 2014 Sep 10.

8.

BODE index and GOLD staging as predictors of 1-year exacerbation risk in chronic obstructive pulmonary disease.

Faganello MM, Tanni SE, Sanchez FF, Pelegrino NR, Lucheta PA, Godoy I.

Am J Med Sci. 2010 Jan;339(1):10-4. doi: 10.1097/MAJ.0b013e3181bb8111.

PMID:
19926966
9.

Reduction of exacerbation frequency in patients with COPD after participation in a comprehensive pulmonary rehabilitation program.

van Ranst D, Stoop WA, Meijer JW, Otten HJ, van de Port IG.

Int J Chron Obstruct Pulmon Dis. 2014 Oct 3;9:1059-67. doi: 10.2147/COPD.S69574. eCollection 2014.

10.

Relationship between the GOLD combined COPD assessment staging system and bacterial isolation.

Aydemir Y, Aydemir Ö, Kalem F.

Int J Chron Obstruct Pulmon Dis. 2014 Sep 27;9:1045-51. doi: 10.2147/COPD.S70620. eCollection 2014.

11.

Predictive properties of different multidimensional staging systems in patients with chronic obstructive pulmonary disease.

Oga T, Tsukino M, Hajiro T, Ikeda A, Nishimura K.

Int J Chron Obstruct Pulmon Dis. 2011;6:521-6. doi: 10.2147/COPD.S24420. Epub 2011 Oct 11.

12.

A comparison of three multidimensional indices of COPD severity as predictors of future exacerbations.

Motegi T, Jones RC, Ishii T, Hattori K, Kusunoki Y, Furutate R, Yamada K, Gemma A, Kida K.

Int J Chron Obstruct Pulmon Dis. 2013;8:259-71. doi: 10.2147/COPD.S42769. Epub 2013 May 31.

13.

[Value of quality of life evaluation in prognosis of chronic obstructive pulmonary disease].

Gu JH, Qiu YJ, Lu YH, Xu XD, Xu ZH.

Zhejiang Da Xue Xue Bao Yi Xue Ban. 2014 Mar;43(2):207-11. Chinese.

PMID:
24782379
14.

Exacerbation-related impairment of quality of life and work productivity in severe and very severe chronic obstructive pulmonary disease.

Solem CT, Sun SX, Sudharshan L, Macahilig C, Katyal M, Gao X.

Int J Chron Obstruct Pulmon Dis. 2013;8:641-52. doi: 10.2147/COPD.S51245. Epub 2013 Dec 10.

15.

Validation of a COPD screening questionnaire and establishment of diagnostic cut-points in a Japanese general population: the Hisayama study.

Tsukuya G, Matsumoto K, Fukuyama S, Crawford B, Nakanishi Y, Ichinose M, Machida K, Samukawa T, Ninomiya T, Kiyohara Y, Inoue H; Hisayama Pulmonary Physiology Study Group.

Allergol Int. 2015 Jan;64(1):49-53. doi: 10.1016/j.alit.2014.06.002. Epub 2014 Dec 17.

16.

[How exactly can we predict the prognosis of COPD].

Atiş S, Kanik A, Ozgür ES, Eker S, Tümkaya M, Ozge C.

Tuberk Toraks. 2009;57(3):289-97. Turkish.

PMID:
19787468
17.

Minimum clinically important difference for the COPD Assessment Test: a prospective analysis.

Kon SS, Canavan JL, Jones SE, Nolan CM, Clark AL, Dickson MJ, Haselden BM, Polkey MI, Man WD.

Lancet Respir Med. 2014 Mar;2(3):195-203. doi: 10.1016/S2213-2600(14)70001-3. Epub 2014 Feb 4.

18.

Emphysematous phenotype is an independent predictor for frequent exacerbation of COPD.

Oh YM, Sheen SS, Park JH, Jin UR, Yoo JW, Seo JB, Yoo KH, Lee JH, Kim TH, Lim SY, Yoon HI, Lee JS, Lee SD.

Int J Tuberc Lung Dis. 2014 Dec;18(12):1407-14. doi: 10.5588/ijtld.14.0205.

PMID:
25517804
20.

Evolution of the COPD Assessment Test score during chronic obstructive pulmonary disease exacerbations: determinants and prognostic value.

Feliz-Rodriguez D, Zudaire S, Carpio C, Martínez E, Gómez-Mendieta A, Santiago A, Alvarez-Sala R, García-Río F.

Can Respir J. 2013 Sep-Oct;20(5):e92-7.

Items per page

Supplemental Content

Write to the Help Desk